News View all news
Top medical journals raise concerns about data in two studies related to COVID-19
Just days after more than 180 scientists raised questions about the statistical analysis and a lack of transparency in a hydroxychloroquine study in The Lancet, the researchers say they have "similar issues" with a recent New England Journal of Medicine study about the safety of heart drugs in COVID-19.
APhA swears in Scott Knoer as CEO
Scott Knoer, MS, PharmD, FASHP, was sworn in Monday as chief executive officer and executive vice president of APhA. "Being sworn in as the leader of this storied organization is the greatest honor of my life," Knoer said during a virtual ceremony witnessed by APhA members and staff.
APhA coronavirus watch: Patients with COVID-19 recover more quickly with remdesivir treatment, clinical trials show
A 5-day course of the investigational antiviral drug remdesivir led to greater clinical improvement for patients with moderate and severe COVID-19 disease in two Phase III SIMPLE trials, according to Gilead Sciences in a June 1 news release. Gilead’s findings support the preliminary results of the Adaptive COVID-19 Treatment Trial (ACTT-1) published in the May 27 issue of the New England Journal of Medicine, which showed that remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with COVID-19.
FDA approves new option to treat heavy menstrual bleeding associated with fibroids
FDA on Friday approved an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate (Oriahnn—AbbVie) capsules, co-packaged for oral use, for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
June 2, 2020
The biggest challenge of our lives
Yesterday was my first official day as executive vice president and CEO of APhA, and I planned to write a blog introducing myself and establishing my goals for the association. Plans don’t mean much…0 comments
June 1, 2020
APhA Swears in Scott J. Knoer as its 13th Chief Executive Officer
Scott J. Knoer, MS, PharmD, FASHP, was sworn in today as the 13th Chief Executive Officer and Executive Vice President of the American Pharmacists Association, during a virtual ceremony witnessed by APhA members and staff.
May 28, 2020
APhA2020 Virtual Keeps Pharmacists Connected to the Profession During COVID-19
In an effort to keep the nation’s pharmacists inspired and connected to the profession as frontline providers during the fight against COVID-19, the American Pharmacists Association (APhA) developed APhA2020 Virtual, an online version of APhA’s Annual Meeting & Exposition, which was cancelled due to the pandemic.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.